Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
16.41
-0.29 (-1.74%)
May 15, 2025, 3:06 PM - Market open
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $2.06 billion as of May 15, 2025. Its market cap has decreased by -64.46% in one year.
Market Cap
2.06B
Enterprise Value
2.16B
1-Year Change
-64.46%
Ranking
Category
Stock Price
$16.41
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $2.06B, an increase of 198.44%. That is a compound annual growth rate of 15.66%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 656.24B |
| Johnson & Johnson | 352.59B |
| AbbVie | 321.03B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 286.76B |
| Abbott Laboratories | 224.46B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |